相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LZ205, a newly synthesized flavonoid compound, exerts anti-inflammatory effect by inhibiting M1 macrophage polarization through regulating PI3K/AKT/mTOR signaling pathway
Dongsheng Bai et al.
EXPERIMENTAL CELL RESEARCH (2018)
An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia
Jianlin Qiao et al.
PLATELETS (2017)
Indirubin Treatment of Lipopolysaccharide-Induced Mastitis in a Mouse Model and Activity in Mouse Mammary Epithelial Cells
Jin-lun Lai et al.
MEDIATORS OF INFLAMMATION (2017)
Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice
Sandra Medina-Moreno et al.
PLOS ONE (2017)
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey et al.
JOURNAL OF CLINICAL MEDICINE (2017)
The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease
Yong-chao Qiao et al.
AUTOIMMUNITY REVIEWS (2017)
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
Caroline M. Hull et al.
DIABETOLOGIA (2017)
Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells
Wenyan Gao et al.
ACTA HISTOCHEMICA (2016)
High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia
Yu Hou et al.
BLOOD (2016)
Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP
Jun Zhong et al.
HEMATOLOGY (2016)
Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells
Hoi-Hin Kwok et al.
SCIENTIFIC REPORTS (2016)
Indirubin derivatives: a patent review (2010-present)
Nicolas Gaboriaud-Kolar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Engagement of the Aryl Hydrocarbon Receptor in Mycobacterium tuberculosis-Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling
Babak Memari et al.
JOURNAL OF IMMUNOLOGY (2015)
Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability
Alexandria Huynh et al.
NATURE IMMUNOLOGY (2015)
The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment
Madhav D. Sharma et al.
SCIENCE ADVANCES (2015)
Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients
Feng Li et al.
IMMUNOLOGIC RESEARCH (2015)
Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia
Shuang Yu et al.
LABORATORY INVESTIGATION (2015)
Indirubin Increases CD4+CD25+Foxp3+ Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice
Aijun Zhang et al.
PLOS ONE (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
Programmed death-1 pathway in cancer and autoimmunity
Ariel Pedoeem et al.
CLINICAL IMMUNOLOGY (2014)
Expression of Programmed Death-1 (PD-1) on CD4+and CD8+T cells in Rheumatoid Arthritis
Shufeng Li et al.
INFLAMMATION (2014)
CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance
Tomohiro Koga et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Pathogenesis of immune thrombocytopenia
Douglas B. Cines et al.
PRESSE MEDICALE (2014)
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Elena Gianchecchi et al.
AUTOIMMUNITY REVIEWS (2013)
Cellular immune dysfunction in immune thrombocytopenia (ITP)
Christopher G. J. McKenzie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura
Jianqin Li et al.
IMMUNOLOGY LETTERS (2013)
Blockade of Programmed Death-1 in Young (New Zealand Black x New Zealand White)F1 Mice Promotes the Suppressive Capacity of CD4+ Regulatory T Cells Protecting from Lupus-like Disease
Maida Wong et al.
JOURNAL OF IMMUNOLOGY (2013)
CD4+CD25+Foxp3+ Regulatory T Cells in the Pathophysiology of Immune Thrombocytopenia
Tetsuya Nishimoto et al.
SEMINARS IN HEMATOLOGY (2013)
B7 family checkpoint regulators in immune regulation and disease
Sabrina Ceeraz et al.
TRENDS IN IMMUNOLOGY (2013)
Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia
Rukhsana Aslam et al.
BLOOD (2012)
The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage
John W. Semple et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia
Yu Hu et al.
HUMAN IMMUNOLOGY (2012)
Effects of High-Dose Dexamethasone on Regulating Interleukin-22 Production and Correcting Th1 and Th22 Polarization in Immune Thrombocytopenia
Jiang Cao et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
Zhenyu Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis
Camille L. Pittet et al.
JOURNAL OF NEUROINFLAMMATION (2011)
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy
Leola Chow et al.
BLOOD (2010)
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
Weili Bao et al.
BLOOD (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Indirubins deplete striatal monoamines in the Intact and MPTP-treated mouse brain and block kainate-induced striatal astrogliosis
Prokopios Magiatis et al.
NEUROTOXICOLOGY AND TERATOLOGY (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25- cells in patients with idiopathic thrombocytopenic purpura
Xiao-Lin Zhang et al.
BLOOD (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
Roberto Stasi et al.
BLOOD (2008)
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura
Jin Yu et al.
BLOOD (2008)
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Sokol Haxhinasto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
Stephan Sauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes
J Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
MJI Ansari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
分享论文
